Human Factors Validation and Usability Testing of the IKE Age-Gating System
NCT ID: NCT06952569
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2025-02-18
2025-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
NCT00754091
PureWick⢠Adolescent Study
NCT06631313
Use of Wearable Digital Sensors After mRNA Vaccination in Adults
NCT05440318
Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018
NCT06056011
Investigational On-body Injector Clinical Study
NCT05553418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
IKE developed a smartphone application which identifies and age-verifies users and works in conjunction with a Bluetooth low energy (BLE) chip to restrict connecting to and activating a device by a users age. The intention is to use this in ENDs devices, and therefore the age limit was set to 21 years. This feature is generally referred to as "age-gating."
The purpose of the study is to:
* Generally establish the ability of individuals to successfully download and use the IKE application
* Confirm the identification and age-verification application works effectively to prevent those under 21 from enabling the IKE application
* Confirm the identification and age-verification application works effectively to allow those 21 years of age or older to enable the IKE application
* Establish that only individual over 21 years of age is able to connect a device to the IKE application via Bluetooth
Upon successful Bluetooth connection to the device via the IKE application:
* Confirm the Maximum Idle Time function works by disconnecting the device and powering the device off within a maximum of 15 minutes
* Confirm the Out of Bluetooth Range function works specific to connection of the Vape device to the smartphone (Vape device will be placed in Faraday bag to force disconnect from smartphone) and the user can re-activate the device
* Confirm users are able to reactivate the same device after either Maximum Idle Time disconnect or Out of Bluetooth Range disconnect
Establish the ability of an identity and age-verified individual to log-in to the application on a secondary device (in this case a tablet) and effectively connect the device using Bluetooth while simultaneously forcing disconnection of the previously connected device
Further, the research is designed to have participants use the smartphone application in as natural as possible setting without direct instruction to simulate a real-world use setting.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age 18-20, non user
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Age 21-24, Smoker, Vape user or Both
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Age 22-44, Smoker, Vape user or Both
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Age 45-64, Smoker, Vape user or Both
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Age 65 or older, Smoker, Vape user or Both
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Age 65 or older, Non-user
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IKE System
Age-gate the access and activation of a device to authorized users of legal age
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ages 18 and older
3. Have a valid driver's license or US government-issued identification with picture
4. Currently use a smartphone with an iOS (Apple) or Android operating system
5. Indicate somewhat (3), very (4), or extremely (5) comfortable using smartphone applications on intake questionnaire
6. Able and willing to comply with all study requirements
7. Review and sign informed consent
Exclusion Criteria
2. Among 21-64 years of age, do not currently use cigarettes or vape products
3. Do not own or use a smartphone with an iOS (Apple) or Android operating system
4. Unable to download any smartphone application
5. Employees of or household member employed in advertising/marketing, market research, healthcare, legal field, news and media, or local, state or US Federal government to minimize bias and to protect any proprietary product information that will be disclosed in the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IKE Tech
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alder Weiner, MARC Research facility partner
Los Angeles, California, United States
Focus Center, MARC Research facility partner
Chicago, Illinois, United States
L&E Research, MARC Research facility partner
New York, New York, United States
Creative Consumer Research, MARC Research facility partner
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00083344
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.